Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
The Journal of Infectious Diseases2008Vol. 197(5), pp. 667–675
Citations Over TimeTop 1% of 2008 papers
David I. Bernstein, Kathryn M. Edwards, Cornelia L. Dekker, Robert B. Belshe, H. Keipp Talbot, Irene Graham, Diana L. Noah, Fenhua He, Heather Hill
Abstract
ClincalTrials.gov identifier: http://www.clinicaltrials.gov/ct2/show/NCT00280033?term= NCT00280033&rank=1 NCT00280033 .
Related Papers
- → Prevalence of Antibodies against Avian Influenza A (H5N1) Virus among Cullers and Poultry Workers in Ho Chi Minh City, 2005(2009)43 cited
- → Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally?(2010)32 cited
- → Serologic cross-reactivity among humans and birds infected with highly pathogenic avian influenza A subtype H5N1 viruses in China(2010)7 cited
- → Immunogenicity ofEscherichia coli O antigen in upper urinary tract infection(1975)3 cited
- Expression of VP2 Hydrophilic Coding-region of Canine Parvovirus and Analysis of Immunogenicity(2009)